Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic Mice
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Primary and secondary hypertriglyceridemia is common in the general population, but the biochemical basis for this disease is largely unknown. With the use of transgenic technology, two lines of mice were created that express the human apolipoprotein CIII gene. One of these mouse lines with 100 copies of the gene was found to express large amounts of the protein and to be severely hypertriglyceridemic. The other mouse line with one to two copies of the gene expressed low amounts of the protein, but nevertheless manifested mild hypertriglyceridemia. Thus, overexpression of apolipoprotein CIII can be a primary cause of hypertriglyceridemia in vivo and may provide one possible etiology for this common disorder in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High ApoC-III levels were shown to increase total triglyceride levels by an accumulation of VLDL and chylomicrons [166–169]”
From Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention (2023) · cites this paper as [167]
In the citing paper
“These data are consistent with previous studies showing that transgenic mice with overexpression of human apolipoprotein C3 had hypertriglyceridemia due to decreased lipoprotein lipase activity,16”
From Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease (2010) · cites this paper as [16]
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,585
Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein
Virgil Brown, W., & Baginsky, M. L. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80149-9 · Cited by 491
Ginsberg, H. N., Le, N. A., Goldberg, I. J., Gibson, J. C., Rubinstein, A., Wang-Iverson, P., Norum, R., & Brown, W. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112713 · Cited by 424
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
Wang, C. S., McConathy, W. J., Kloer, H. U., & Alaupovic, P. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111711 · Cited by 414
Karathanasis, S. K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6374 · Cited by 358
PLASMA TRIGLYCERIDE AS A RISK FACTOR FOR CORONARY HEART DISEASE
AUSTIN, M. A. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115130 · Cited by 352
Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery Disease
Norum, R. A., Lakier, J. B., Goldstein, S., Angel, A., Goldberg, R. B., Block, W. D., Noffze, D. K., Dolphin, P. J., Edelglass, J., Bogorad, D. D., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062503 · Cited by 304
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112926 · Cited by 261
Self-citationWalsh, A., Ito, Y., & Breslow, J. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83374-9 · Cited by 241
Self-citation
Research works printed but not linked: 2
- COLE, T.G., BIOCOMMUNIQUE 4: 4 (1988).
- PROTTER, A. A., DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY 3: 449 (1984).
Cited by
Items 301–400 of 543
Muendlein, A., Saely, C. H., Marte, T., Schmid, F. M., Koch, L., Rein, P., Langer, P. H., Aczél, S., & Drexel, H. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.10.030 · Cited by 26
Role of thyroid hormone in the expression of apolipoprotein A-IV and C-III genes in rat liver.
Lin-Lee, Y.-C., Strobl, W., Soyal, S. M., Peck‐Radosavljevic, M., Song, M., Gotto, A. M., & Patsch, W. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40752-7 · Cited by 26
Frenkel, B., Bishara-Shieban, J., & Bar‐Tana, J. (1994) · Biochemical Journal · doi:10.1042/bj2980409 · Cited by 25
Inhibition of ApoCIII: the next PCSK9?
Moens, S. J. B., van Capelleveen, J. C., & Stroes, E. S. G. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000130 · Cited by 25
Alberici, L. C., Oliveira, H. C. F., Catharino, R. R., Vercesi, A. E., Eberlin, M. N., & Alberici, R. M. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5208-8 · Cited by 27
Allele-specific Differences in Apolipoprotein C-III mRNA Expression in Human Liver
Esterbauer, H., Hell, E., Krempler, F., & Patsch, W. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.3.331 · Cited by 25
Alberici, L. C., Oliveira, H. C. F., Bighetti, E. J. B., de Faria, E. C., Degaspari, G. R., de Souza, C. T., & Vercesi, A. E. (2003) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1027343915452 · Cited by 28
Katsuren, K. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(01)00106-8 · Cited by 24
Hussain, M. M., Goldberg, I. J., Weisgraber, K. H., Mahley, R. W., & Innerarity, T. L. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.7.1407 · Cited by 24
Cardiovascular research in transgenic animals
Field, L. J. (1991) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(91)90018-a · Cited by 24
May, L. T., Bartolo, B. A. D., Harrison, D. G., Guzik, T. J., Drummond, G. R., Figtree, G. A., Ritchie, R. H., Rye, K., & de Haan, J. B. (2022) · Clinical Science · doi:10.1042/cs20210862 · Cited by 24
Roles of Vitamin A Metabolism in the Development of Hepatic Insulin Resistance
Chen, G. (2013) · ISRN Hepatology · doi:10.1155/2013/534972 · Cited by 27
Anisimov, S. V., Volkova, M., Lenskaya, L. V., Khavinson, V. K., Soloveva, D. V., & Schwartz, E. I. (2001) · The Journals of Gerontology Series A · doi:10.1093/gerona/56.1.b27 · Cited by 24
Apolipoprotein Polymorphisms and Familial Hypercholesterolemia
Dedoussis, G. V. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.9.1179 · Cited by 23
Størling, J., Juntti‐Berggren, L., Olivecrona, G., Prause, M. C. B., Berggren, P., & Mandrup-Poulsen, T. R. (2011) · Endocrinology · doi:10.1210/en.2010-1422 · Cited by 23
Wang, J., Liu, N., Liu, Z., Li, Y., Song, C. Y., Yuan, H., Li, Y., Zhao, X., & Lü, H. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.09.004 · Cited by 25
Jayanthi, S., Buie, S., Moore, S., Herning, R. I., BETTER, W. E., Wilson, N. M., Contoreggi, C. S., & Cadet, J. L. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.50 · Cited by 25
Georgopoulos, S., Kan, H. Y., Reardon-Alulis, C., & Zannis, V. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.24.4919 · Cited by 26
Han, X., Wang, T., Zhang, J., Liu, X., Li, Z., Wang, G., Song, Q., Pang, D., Ouyang, H., & Tang, X. (2015) · Biology Open · doi:10.1242/bio.201410900 · Cited by 23
Bredie, S. J. H., Westerveld, H. T., Knipscheer, H. C., de Bruin, T. W., Kastelein, J. J., & Stalenhoef, A. F. (1996) · The Netherlands Journal of Medicine · doi:10.1016/0300-2977(96)00015-0 · Cited by 25
Aguie, G. A., Rader, D. J., Barthelemy-Clavey, V., Traber, M. G., Torpier, G., Kayden, H. J., Fruchart, J., Brewer, H. B., & Castro, G. R. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05605-x · Cited by 22
Feussner, G., Scharnagl, H., Scherbaum, C., Acar, J., Dobmeyer, J., Lohrmann, J., Wieland, H., & März, W. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39106-9 · Cited by 21
El-Aziz, T. A. A., Mohamed, R. H., & Hashem, R. M. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0813-6 · Cited by 21
Bighetti, E. J. B., Patrício, P. R., Casquero, A. C., Berti, J. A., & Oliveira, H. C. F. (2009) · Lipids in Health and Disease · doi:10.1186/1476-511x-8-50 · Cited by 21
APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice
Cheng, X., Yamauchi, J., Lee, S., Zhang, T., Gong, Z., Muzumdar, R. H., Qu, S., & Dong, H. H. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.765917 · Cited by 23
Huang, D.-P., Yuan, W., Li, H., Li, S., Chen, Z., & Yang, H. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6427 · Cited by 21
Apolipoprotein CIII and diabetes. Is there a link?
Christopoulou, E. C., Tsimihodimos, V., Filippatos, T. D., & Elisaf, M. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3118 · Cited by 22
Šeda, O., Šedová, L., Kazdová, L., Krenová, D., & Křen, V. (2002) · Folia Biologica · doi:10.14712/fb2002048030081 · Cited by 22
de Man, F. H. A. F., de Beer, F., van der Laarse, A., Jansen, H., Leuven, J. A. G., Souverijn, J. H. M., Vroom, T. F. F. P., Schoormans, S. C. M., Fruchart, J., Havekes, L. M., et al. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00409-3 · Cited by 21
Weinberg, R. B. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39927-2 · Cited by 27
Wu, C., Zou, L., Shi, S., Tong, Z., Shen, X., Yang, D., Ke, L., Li, W., & Li, J. (2017) · Pancreatology · doi:10.1016/j.pan.2017.06.006 · Cited by 20
The Expression of Intact and Mutant Human apoAI/CIII/AIV/AV Gene Cluster in Transgenic Mice
Gao, J., Wei, Y., Huang, Y., Liu, D., Liu, G., Wu, M., Wu, L., Zhang, Q.-J., Zhang, Z., Zhang, R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409883200 · Cited by 20
Hirano, T., Takahashi, T., Saito, S., Tajima, H., Ebara, T., & Adachi, M. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.4.e665 · Cited by 19
Macromolecular Interactions of Lipoprotein Lipase (LPL)
Wheless, A., Gunn, K. H., & Neher, S. B. (2024) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-58843-3_8 · Cited by 20
Huard, K., Bourgeois, P., Rhainds, D., Falstrault, L., Cohn, J. S., & Brissette, L. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.01.005 · Cited by 19
Impaired postprandial lipemic response in chronic kidney disease
Saland, J. M., Satlin, L. M., Zalsos-Johnson, J., Cremers, S., & Ginsberg, H. N. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.031 · Cited by 19
Impaired Myocardial Vasodilation During Hyperemic Stress With Dipyridamole in Hypertriglyceridemia
Yokoyama, I., Ohtake, T., Momomura, S., Yonekura, K., Nishikawa, J., Sasaki, Y., & Omata, M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00166-1 · Cited by 19
[1] Apolipoproteins: Pathophysiology and clinical implications
Patsch, W., & Gotto, A. M. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)63003-1 · Cited by 26
Genetic Susceptibility to Hepatic Steatosis
Diehl, A. M. (2010) · New England Journal of Medicine · doi:10.1056/nejme1000206 · Cited by 19
Apolipoprotein A-V gene therapy for disease prevention/treatment: a critical analysis
Trudy, M., Vineeta, S., & Robert, O. (2016) · The Journal of Biomedical Research · doi:10.7555/jbr.30.20150059 · Cited by 18
Han, Y., Yang, Z., Ding, X., & Yu, H. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.158322 · Cited by 18
Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD
Chhabra, S., Narang, R., Ramakrishnan, L., Vasisht, S., Agarwal, D. P., Srivastava, M., Manchanda, S. C., & Das, N. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000021345.31556.c9 · Cited by 18
Puppala, J., Bhrugumalla, S., Kumar, A., Siddapuram, S. P., Viswa, P. D. K., Kondawar, M., Jyothy, A., & Munshi, A. (2014) · Indian Journal of Gastroenterology · doi:10.1007/s12664-014-0504-9 · Cited by 18
Marvel, S. W., Rotroff, D. M., Wagner, M. J., Buse, J. B., Havener, T. M., McLeod, H. L., Motsinger‐Reif, A. A., & The ACCORD/ACCORDion Investigators (2017) · PeerJ · doi:10.7717/peerj.3187 · Cited by 20
Dergunov, A. D. (2004) · Biochemistry (Moscow) · doi:10.1023/b:biry.0000040195.34986.93 · Cited by 19
Effect of sucrose diet on expression of apolipoprotein genes A-I, C-III and A-IV in rat liver
Peck‐Radosavljevic, M., Lin-Lee, Y.-C., Soyal, S. M., Strobl, W., Seelos, C., Gotto, A. M., & Patsch, W. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90018-c · Cited by 18
Genetic determinants of atherosclerosis-related dyslipidemias and their clinical implications
Galton, D. J. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(96)06443-1 · Cited by 25
Schonfeld, G., Aguilar-Salina, C., & Elias, N. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00037-x · Cited by 18
Silver-enhanced radial immunodiffusion assay of plasma apolipoproteins.
Ishida, B. Y., & Paigen, B. J. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41423-3 · Cited by 18
Bhanushali, A. A., & Das, B. R. (2010) · Journal of Community Genetics · doi:10.1007/s12687-010-0025-x · Cited by 17
Lahiry, P., Ban, M. R., Pollex, R. L., Sawyez, C. G., Huff, M. W., Young, T. K., Bjerregaard, P., & Hegele, R. A. (2007) · International Journal of Circumpolar Health · doi:10.3402/ijch.v66i5.18311 · Cited by 17
Development of Antisense Drugs for Dyslipidemia
Yamamoto, T., Wada, F., & Harada‐Shiba, M. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv16001 · Cited by 19
New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia
Groenendijk, M., Cantor, R. M., de Bruin, T. W., & Dallinga‐Thie, G. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31678-3 · Cited by 17
Rimland, D., Guest, J., Hernández, I., del Río, C., Le, N., & Brown, W. V. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00316.x · Cited by 18
Yang, C. Y., Gu, Z., Nv, V., Pownall, H. J., Lee, B., Yang, M., Xie, Y., Guyton, J., Vlasik, T. N., & Fruchart, J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36961-3 · Cited by 17
Baroukh, N., Ostos, M., Vergnes, L., Recalde, D., Staels, B., Fruchart, J., Ochoa, A., Castro, G., & Zakin, M. M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02621-7 · Cited by 20
Association between APOC3 polymorphisms and non-alcoholic fatty liver disease risk: a meta-analysis
Wang, J., Ye, C., & Fei, S. (2020) · African Health Sciences · doi:10.4314/ahs.v20i4.34 · Cited by 20
Genetics of Lipid Traits and Relationship to Coronary Artery Disease
Keenan, T. E., & Rader, D. J. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0396-9 · Cited by 19
Ceccarelli, V., Nocentini, G., Riccardi, C., Ayroldi, E., Nardo, P. D., Roberti, R., Binaglia, L., & Vecchini, A. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0609-0 · Cited by 16
Sprecher, D. L., Hein, M. J., & Laskarzewski, P. M. (1994) · Circulation · doi:10.1161/01.cir.90.3.1177 · Cited by 16
Apolipoprotein CIII: A Link Between Hypertriglyceridemia and Vascular Dysfunction?
Caron, S., & Staels, B. (2008) · Circulation Research · doi:10.1161/circresaha.108.189860 · Cited by 16
Lappas, M., Georgiou, H. M., Velagic, A., Willcox, J. C., Permezel, M., & Shub, A. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0577-7700 · Cited by 16
Shaik, A., & Rosenson, R. S. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07168-0 · Cited by 16
Chang, P., Lee, C., Hsu, H., Lin, H., Chien, K., Chen, M.-F., Chen, C., Lee, Y., & Yang, C.-Y. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-162 · Cited by 16
Lutkewitte, A. J., McCommis, K. S., Schweitzer, G. G., Chambers, K. T., Graham, M. J., Wang, L., Patti, G. J., Hall, A. M., & Finck, B. N. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m089722 · Cited by 15
Kosuge, K., Miida, T., Takahashi, A., Obayashi, K., Ito, M., Ito, T., Soda, S., Ozaki, K., Hirayama, S., Hanyu, O., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.05.037 · Cited by 16
Insulin-treated Zucker diabetic fatty rats retain the hypertriglyceridemia associated with obesity
Sparks, J. D., Shaw, W. N., Corsetti, J. P., Bolognino, M., Pesek, J. F., & Sparks, C. E. (2000) · Metabolism · doi:10.1053/meta.2000.17736 · Cited by 15
Significant association of APOA5 and APOC3 gene polymorphisms with meat quality traits in Kele pigs
Hui, Y. T., Yang, Y. Q., Liu, R. Y., Zhang, Y. Y., Xiang, C. J., Liu, Z. Z., Ding, Y. H., Zhang, Y. L., & Wang, B. (2013) · Genetics and Molecular Research · doi:10.4238/2013.september.13.8 · Cited by 15
Distribution of seven ApoC-III glycoforms in plasma, VLDL, IDL, LDL and HDL of healthy subjects
Rodríguez, M. M., Rehues, P., Iranzo, V., Mora, J. D., Balsells, C., Guardiola, M., & Ribalta, J. (2021) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104398 · Cited by 14
Genetic and clinical markers of elevated liver fat content in overweight and obese hispanic children
Walker, R. W., SINATRA, F. R., Hartiala, J., Weigensberg, M. J., Spruijt‐Metz, D., Alderete, T. L., Goran, M. I., & Allayee, H. (2013) · Obesity · doi:10.1002/oby.20523 · Cited by 14
Structure and Function of the Lipolysis Stimulated Lipoprotein Receptor
Stenger, C., Corbier, C., & Frances, T. (2012) · InTech eBooks · doi:10.5772/34657 · Cited by 14
Brautbar, A., Virani, S. S., Belmont, J. W., Nambi, V., Jones, P. H., & Ballantyne, C. M. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m020404 · Cited by 14
Filippatos, T. D., Tsimihodimos, V., Kostapanos, M. S., Kostara, C. E., Bairaktari, E. T., Kiortsis, D. N., Tselepis, A. D., & Elisaf, M. (2008) · Cited by 15
Zhang, J.-Z., Xie, X., Ma, Y.-T., Zheng, Y., Yang, Y., Li, X., Fu, Z.-Y., Dai, C.-F., Zhang, M., Yin, G.-T., et al. (2016) · Aging and Disease · doi:10.14336/ad.2015.0709 · Cited by 15
Takahashi, Y., Inoue, J., Kagechika, H., & Sato, R. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.12.050 · Cited by 14
Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice
Liu, Y., Cheng, X., Zhang, T., Lee, S., Yamauchi, J., Xiao, X., Gittes, G. K., Qu, S., Jiang, C., & Dong, H. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.707885 · Cited by 16
Attia, N., Durlach, V., Cambilleau, M., Roche, D., & Girard-Globa, A. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00337-8 · Cited by 14
Espino-Montoro, A., Barrios-Artillo, M., López‐Chozas, J. M., Cayuela, A., Stiefel, P., & Villar, J. R. (2003) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(03)80011-x · Cited by 14
Hegele, R. A. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(96)00167-1 · Cited by 16
Expression and secretion of human apolipoprotein A‐I in the heart
Baroukh, N., Lopez, C. E., Saleh, M., Recalde, D., Vergnes, L., Ostos, M. A., Fiette, L., Fruchart, J., Castro, G. R., Zakin, M. M., et al. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01429-7 · Cited by 14
Yang, C.-Y., Gu, Z., Xie, Y.-H., Nv, V., Yang, M., Yeshurun, D., Quion, J. A., & Gotto, A. M. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05899-6 · Cited by 14
Li, W., Wang, Y., Huang, R., Feng, L., Xu, G., Wang, W., & Xue, S. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07789-0 · Cited by 16
Serum Protein KNG1, APOC3, and PON1 as Potential Biomarkers for Yin‐Deficiency‐Heat Syndrome
Liu, C., Mao, L., Ping, Z., Jiang, T., Wang, C., Chen, Z., Li, Z., & Li, J. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/5176731 · Cited by 13
Genetic variation in insulin‐induced kinase signaling
Wang, I. X., Ramrattan, G., & Cheung, V. G. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156250 · Cited by 15
Pek, S. L. T., Sum, C. F., Yeoh, L. Y., Lee, S. B. M., Tang, W. E., Lim, S. C., & Subramaniam, T. (2017) · Metabolism · doi:10.1016/j.metabol.2017.03.016 · Cited by 14
Mitochondrial Adaptive Responses to Hypertriglyceridemia and Bioactive Lipids
Alberici, L. C., & Oliveira, H. C. F. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0180 · Cited by 12
Alberici, L. C., Paim, B. A., Zecchin, K. G., Mirandola, S. R., Pestana, C. R., Castilho, R. F., Vercesi, A. E., & Oliveira, H. C. F. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-87 · Cited by 12
The Future of Lipid-Lowering Therapy
Zwol, W. H.-V., Rimbert, A., & Kuivenhoven, J. A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071085 · Cited by 14
Kateifides, A. K., Gorshkova, I. N., Duka, A., Chroni, A., Kardassis, D., & Zannis, V. I. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m012989 · Cited by 12
Larsson, M., Allan, C. M., Heizer, P. J., Tu, Y., Sandoval, N. P., Jung, R. S., Walzem, R. L., Beigneux, A. P., Young, S. G., & Fong, L. G. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m083832 · Cited by 12
Yamamoto, T., Obika, S., Nakatani, M., Yasuhara, H., Wada, F., Shibata, E., Shibata, M., & Harada‐Shiba, M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.004 · Cited by 11
Ondrušková, N., Honzík, T., Kytnarová, J., Matoulek, M., Zeman, J., & Hansíková, H. (2015) · Prague Medical Report · doi:10.14712/23362936.2015.48 · Cited by 11
Transcriptional Regulation of the Human Apolipoprotein Genes
Zannis, V. I., Kardassis, D., Ogami, K., Hadzopoulou‐Cladaras, M., & Cladaras, C. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5904-3_1 · Cited by 13
Noll, B., Hackler, R., Pelzer, M., Pelzer, S., Nusser, P., Maisch, B., Schaefer, J. R., & Steinmetz, A. (1999) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1999.100 · Cited by 11
Halpern, M. J. (1995) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(95)00004-6 · Cited by 13
The apolipoprotein AICIII-AIV gene cluster: sequence of the ApoCIII-ApoAIV intergenic region
Omori, K., Vergnes, L., Zakin, M. M., & Ochoa, A. (1995) · Gene · doi:10.1016/0378-1119(95)00063-c · Cited by 11
Heli�, T., Palotie, A. V., Sane, T., Tikkanen, M., & Kontula, K. (1994) · Human Genetics · doi:10.1007/bf00208282 · Cited by 11
Triglycerides: the past, the present, and the future
Braunwald, E. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae515 · Cited by 15
Monogenic causes of elevated HDL cholesterol and implications for development of new therapeutics
Larach, D. B., Cuchel, M., & Rader, D. J. (2013) · Clinical Lipidology · doi:10.2217/clp.13.73 · Cited by 10
Clemente‐Postigo, M., Queipo‐Ortuño, M. I., Valdivielso, P., Tinahones, F. J., & Cardona, F. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.08.014 · Cited by 10
Metadata
- Authors
- Ito, Y., Azrolan, N., O'Connell, A., Walsh, A., & Breslow, J. L.
- Affiliations
- Rockefeller University (US)
- Venue
- Science
- Published
- 1990-08-17
- Volume
- 249
- Issue
- 4970
- Pages
- 790-793
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1963872182
- Semantic Scholar
- be3dbcf0ed6239b54ab96520181db05f1ba0399f
- Cited by
- 539
- References
- 32
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 7 · 2023: 9 · 2022: 7 · 2021: 10 · 2020: 9 · 2019: 16 · 2018: 10 · 2017: 17 · 2016: 13 · 2015: 15 · 2014: 16 · 2013: 18 · 2012: 7
- FWCI
- 21.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl033714-17, 5r37hl036461-09)
- National Heart, Lung, and Blood Institute (HL 33714, HL-36461, HL-33435)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- hypertriglyceridemia, apolipoprotein C-III, transgenic mice, gene overexpression, primary hypertriglyceridemia, secondary hypertriglyceridemia, triglyceride metabolism, gene dosage
- MeSH terms
- Animals, Apolipoproteins C, Chylomicrons, Cloning, Molecular, DNA Restriction Enzymes, DNA, Recombinant, Humans, Lipoproteins, VLDL, Mice, Inbred CBA, Mice, Inbred C57BL, Mice, Transgenic, Nucleic Acid Hybridization, RNA, Messenger, Triglycerides, Hypertriglyceridemia, Gene Expression, Mice, Apolipoprotein C-III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.